FBRX - Forte Biosciences Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-16    (Delayed quote data   2026-02-10)
Last
 29.48		 Change
 ⇓ -0.33   (-1.11%)		 Volume
  231,320
Open
 29.73		 High
 31.18		 Low
 28.96
8EMA (Daily)
 30.20		 40EMA (Daily)
 27.99		 50EMA (Daily)
 26.86		 STO (Daily)
 32.678		 MACD Hist (Daily)
 -0.678
8EMA (Weekly)
 27.737		 40EMA (Weekly)
 18.54		 50EMA (Weekly)
 17.09		 STO (Weekly)
 79.739		 MACD Hist (Weekly)
 0.128
Company Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com